1. Epigenetics Protein Tyrosine Kinase/RTK JAK/STAT Signaling Stem Cell/Wnt
  2. JAK
  3. RAI-20

RAI-20 (H018) 是一种口服有效的 JAK1/JAK2 双重抑制剂 (IC50=15.1 和 22.7 nM)。RAI-20 具备优异的药代动力学特性,包括血浆稳定性、全身暴露量以及较长的半衰期。在胶原诱导性关节炎大鼠模型中,RAI-20 展现出显著的抗炎和抗关节炎活性,有效降低了足爪肿胀体积和关节炎指数。RAI-20 可用于类风湿关节炎发病机制的研究。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

我们将采用定制合成服务的方式为您快速提供所需产品和技术服务

RAI-20

RAI-20 Chemical Structure

CAS No. : 2549180-90-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

查看 JAK 亚型特异性产品:

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

RAI-20 (H018) is an orally active JAK1/JAK2 dual inhibitor (IC50=15.1 and 22.7 nM). RAI-20 exhibits excellent pharmacokinetic properties, including plasma stability, systemic exposure, and a long half-life. In a collagen-induced arthritis rat model, RAI-20 shows significant anti-inflammatory and anti-arthritic activities, effectively reducing paw swelling volume and arthritis index. RAI-20 can be used for research on the pathogenesis of rheumatoid arthritis[1].

IC50 & Target

JAK2

22.7 nM (IC50)

JAK1

15.1 nM (IC50)

体外研究
(In Vitro)

RAI-20 抑制 Ba/F3 细胞增殖,IC50 为 1.21 μM[1]
RAI-20 抑制人全血细胞中 IL-6 诱导的 pSTAT1 表达,IC50 为 1.45 μM[1]
RAI-20 具有优良的体外药代动力学特性,包括人血浆稳定性强、肝微粒体代谢中等、血浆蛋白结合率高、无显著 CYP 抑制作用,以及 IC50 为 11.5 μM 的 hERG 抑制活性[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: Ba/F3 cell
Concentration: 3x serial dilutions
Incubation Time: under standard cell culture conditions
Result: Inhibited Ba/F3 cell proliferation with an IC50 of 1.21 μM.
药代动力学
(Parmacokinetics)
Species Dose Route T1/2 Tmax Cmax AUC AUC0-∞
Rat[1] 5 mg/kg p.o. 3.06 h 0.92 h 527.64 ng/mL / 3432.96 ng·h/mL
Rat[1] 10 mg/kg p.o. 7.4 h 1.0 h 2402.5 ng/mL 10941.5 ng·h/mL /
体内研究
(In Vivo)

RAI-20 (2-10 mg/kg;灌胃;每日给药;连续 14 天 ) 可在胶原诱导性关节炎的 Lewis 大鼠中诱导产生强效、剂量依赖性的抗关节炎活性,其中每日灌胃 10 mg/kg 的剂量对大鼠后爪体积和关节炎指数的降低作用最为显著[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Lewis rats (immunized with type II collagen intradermally at the base of the tail on day 0, followed by a booster immunization on day 7)[1]
Dosage: 2 mg/kg; 3 mg/kg; 5 mg/kg; 10 mg/kg
Administration: p.o.; daily; 14 days
Result: Exhibited dose-dependent reductions in arthritis index, with scores of 8.63, 9.25, 8.00, and 7.25 for the 2 mg/kg, 3 mg/kg, 5 mg/kg, and 10 mg/kg doses, respectively.
Showed lower hind paw volume (3.826 ± 0.075 cm3 at day 28) and arthritis index at every time point from day 17 to day 28 in the 10 mg/kg group compared to other control drugs.
Demonstrated a trend of body weight recovery in all dose groups during days 24-28.
分子量

448.53

Formula

C20H21FN4O3S2

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
RAI-20
目录号:
HY-181929
需求量: